Nicoletti, F <br/><br/>
Blood levels of transforming growth factor-beta 1 (TGF-beta1) are elevated in both relapsing remitting and chronic progressive multiple sclerosis (MS) patients and are further augmented by treatment with interferon-beta 1b (IFN-beta1b).  [electronic resource] 

 -  Clinical and experimental immunology  Jul 1998 
 - 96-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0009-9104 
<br/><br/><label>Standard No.: </label>10.1046/j.1365-2249.1998.00604.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--therapeutic use<br/>Enzyme-Linked Immunosorbent Assay<br/>Female<br/>Humans<br/>Interferon beta-1a<br/>Interferon beta-1b<br/>Interferon-beta--therapeutic use<br/>Male<br/>Multiple Sclerosis--blood<br/>Recombinant Proteins--therapeutic use<br/>Recurrence<br/>Transforming Growth Factor beta--blood